FolioLanternBeta
GHGuardant Health, Inc.

Alex Azar II

Director at Guardant Health, Inc., as of Oct 13, 2026Sold $145K of stock in the past 12 months: 100% under a disclosed plan.

Updated Oct 15, 2026 from SEC filings · covers Oct 16, 2025 to Oct 15, 2026
46%†
share of stake sold at Guardant Health, Inc.
† Measured against shares held at the start plus shares received, because most of the shares sold arrived during the period.
962
shares held after the latest filing, Guardant Health, Inc.
Vested shares reported on Forms 3, 4 and 5 only. Not the insider's whole wealth.
2
companies filed for

Selling by month

Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.

Disclosed planOne dollar scale for every month; the tallest bar is labeled
OctNovDecJanFebMarAprMayJunJulAugSep 2026: $145K under a disclosed plan$145KSepOct

Pattern

What the filings show, past 12 months. Nothing here rates or predicts.

Roles from filings

Every company we track where this person has filed, newest filing first.

CompanyTitleFirst filingLatest filing
Guardant Health, Inc. (GH)DirectorSep 26, 2025Oct 13, 2026
Eli Lilly (LLY)Former Sr. VP, Corp. Affairs & Comm.Jul 3, 2007Jan 29, 2009

Recent filings

The last 3 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.

This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.